ciprofloxacin has been researched along with Kidney Diseases in 48 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A deep-seated Pseudomonas aeruginosa mouse kidney abscess model was used to compare the therapeutic efficacy of clinafloxacin, a fluoroquinolone in clinical trials, with that of clinically relevant standard drugs." | 7.70 | Comparative therapeutic efficacy of clinafloxacin in a Pseudomonas aeruginosa mouse renal abscess model. ( Desaty, TM; Griffin, TJ; Heifetz, CL; Sesnie, JC; Shapiro, MA, 1998) |
| "The pharmacokinetics of ciprofloxacin were evaluated in 11 patients (3 patients with impaired renal function) with advanced liver cirrhosis after a single oral dose of 500 mg." | 7.68 | Pharmacokinetics of ciprofloxacin in liver cirrhosis. ( Borner, K; Hopfenmüller, W; Ruhnke, M; Trautmann, M, 1990) |
| "Treatment by ciprofloxacin (15 mg." | 5.29 | Suppression of renal scarring by prednisolone combined with ciprofloxacin in ascending pyelonephritis in rats. ( Haraoka, M; Kubo, S; Kumazawa, J; Matsumoto, T; Takahashi, K; Tanaka, M, 1994) |
| "We present a case of Achilles tendinitis in a 77-year-old patient with renal dysfunction and a urinary tract infection (UTI) treated with ciprofloxacin 250 mg PO QD." | 3.74 | An elderly patient with fluoroquinolone-associated achilles tendinitis. ( Cinti, SK; Damuth, E; Heidelbaugh, J; Malani, PN, 2008) |
| "A deep-seated Pseudomonas aeruginosa mouse kidney abscess model was used to compare the therapeutic efficacy of clinafloxacin, a fluoroquinolone in clinical trials, with that of clinically relevant standard drugs." | 3.70 | Comparative therapeutic efficacy of clinafloxacin in a Pseudomonas aeruginosa mouse renal abscess model. ( Desaty, TM; Griffin, TJ; Heifetz, CL; Sesnie, JC; Shapiro, MA, 1998) |
| "The pharmacokinetics of ciprofloxacin were evaluated in 11 patients (3 patients with impaired renal function) with advanced liver cirrhosis after a single oral dose of 500 mg." | 3.68 | Pharmacokinetics of ciprofloxacin in liver cirrhosis. ( Borner, K; Hopfenmüller, W; Ruhnke, M; Trautmann, M, 1990) |
| " The dosage regimens were-groups 1 and 2: 400 mg i." | 2.68 | Pharmacokinetics of intravenous ciprofloxacin in normal and renally impaired subjects. ( Blum, R; Heller, AH; Lettieri, J; Millikin, S; Shah, A; Sica, D, 1996) |
| " Pharmacokinetic parameters were analyzed, assuming an open two-compartment model with first-order input and elimination." | 2.66 | Ciprofloxacin pharmacokinetics in patients with normal and impaired renal function. ( Ebert, SC; Gasser, TC; Graversen, PH; Madsen, PO, 1987) |
| "Ciprofloxacin has been reported to interact with cyclosporine during concomitant use through an interaction with the cytochrome P-450 system or by additive nephrotoxicity." | 2.39 | Does ciprofloxacin interact with cyclosporine? ( Hoey, LL; Lake, KD, 1994) |
| "Ciprofloxacin has a slightly higher extent of metabolism, while temafloxacin probably has a higher transintestinal elimination." | 2.38 | Comparative pharmacokinetics of ciprofloxacin and temafloxacin in humans: a review. ( Kinzig, M; Mahr, G; Muth, P; Naber, KG; Sorgel, F, 1991) |
| "Ciprofloxacin is a synthetic broad-spectrum antimicrobial agent of fluoroquinolone family." | 1.43 | Melatonin can attenuate ciprofloxacin induced nephrotoxicity: Involvement of nitric oxide and TNF-α. ( Ahangar, N; Ashari, S; Shaki, F, 2016) |
| "Ciprofloxacin is a commonly used antibiotic." | 1.40 | Ciprofloxacin-induced crystal nephropathy. ( Ben Hmida, M; Ben Mahmoud, L; Boudawara, T; Hachicha, J; Jarraya, F; Kammoun, K; Kharrat, M; Makni, S; Zeghal, K, 2014) |
| "Ciprofloxacin treatment reduced the viral load and improved the clinical findings." | 1.38 | BK virus nephropathy developing after renal transplantation and its treatment with ciprofloxacin: a case report. ( Bakirdoven, S; Cekmen, MB; Sayan, M; Yilmaz, A, 2012) |
| "DRESS syndrome was diagnosed based on clinical and other findings." | 1.36 | DRESS syndrome with mild manifestations as a diagnostic and therapeutic problem: case report. ( Artuković, M; Kustelega, J; Lugović-Mihić, L, 2010) |
| "Surveillance of ciprofloxacin usage in a pediatric population failed to demonstrate serious or unusually high rates of any adverse events, including joint toxicity." | 1.30 | Ciprofloxacin safety in a pediatric population. ( Jick, S, 1997) |
| "Schematic dosage adjustments for aminoglycosides, vancomycin, and ciprofloxacin were derived from published data on the prolongation of elimination half-lives in patients with renal impairment." | 1.30 | Dosage adjustment of antiinfective therapy in patients with renal impairment. ( Borner, K; Eckhardt, A; Keller, F; Zellner, D, 1997) |
| "Percutaneous drainage of renal hydatid cysts is a safe and effective method for preventing renal loss, and decreasing morbidity and the duration of hospital stay." | 1.29 | Percutaneous drainage of renal hydatid cyst: early results and follow-up. ( Agarwal, MR; Goel, MC; Misra, A, 1995) |
| "Renal scarring could not be prevented in the group in which prednisolone was administered in the period during which the urethra was regularly being clamped." | 1.29 | Effect of prednisolone on ascending renal infection due to biofilm disease and lower urinary tract obstruction in rats. ( Haraoka, M; Kubo, S; Kumazawa, J; Matsumoto, T; Takahashi, K; Tanaka, M, 1995) |
| " Pharmacokinetic parameters were analyzed by assuming an open two-compartment model." | 1.29 | [The pharmacokinetics of ciprofloxacin in patients with renal function of various degrees]. ( Sun, ZM; Wang, HY; Yu, H, 1994) |
| "Treatment by ciprofloxacin (15 mg." | 1.29 | Suppression of renal scarring by prednisolone combined with ciprofloxacin in ascending pyelonephritis in rats. ( Haraoka, M; Kubo, S; Kumazawa, J; Matsumoto, T; Takahashi, K; Tanaka, M, 1994) |
| "Renal parenchymal malacoplakia is a rare cause of renal failure." | 1.28 | Renal malacoplakia with papillary necrosis and renal failure. ( Kohn, OF; Mokrzycki, MH; Yamase, H, 1992) |
| "The effect of renal function on the bioavailability of ciprofloxacin was studied in 21 subjects with measured creatinine clearances ranging from 0 to 8." | 1.28 | Effect of renal function on the bioavailability of ciprofloxacin. ( Drusano, GL; Forrest, A; Plaisance, KI; Standiford, HC; Weir, MR, 1990) |
| "Fleroxacin was well tolerated by all subjects." | 1.28 | Pharmacokinetics and metabolism of intravenous and oral fleroxacin in subjects with normal and impaired renal function and in patients on continuous ambulatory peritoneal dialysis. ( Brandt, R; Frey, FJ; Heizmann, P; Stuck, AE; Weidekamm, E, 1989) |
| " On the basis of these data, a dosage adjustment strategy, which incorporates the severity of infection and the size and renal function of the patient, was developed." | 1.27 | Relationships between renal function and disposition of oral ciprofloxacin. ( Drusano, GL; Forrest, A; Leslie, J; Plaisance, KI; Standiford, HC; Weir, M, 1988) |
| "Ciprofloxacin is a new quinolone carboxylic acid with a broad spectrum of activity against common nosocomial pathogens." | 1.27 | An overview of the pharmacology of intravenously administered ciprofloxacin. ( Drusano, GL, 1987) |
| "We examined the pharmacokinetic behavior of 200 mg of ciprofloxacin administered intravenously to 32 volunteers whose renal function as measured by creatinine clearance ranged from 0 to 8." | 1.27 | Pharmacokinetics of intravenously administered ciprofloxacin in patients with various degrees of renal function. ( Drusano, GL; Emm, T; Forrest, A; Plaisance, K; Standiford, HC; Weir, M, 1987) |
| " Pharmacokinetic parameters were calculated on a two compartment open model." | 1.27 | Pharmacokinetics of ciprofloxacin in healthy volunteers and patients with impaired kidney function. ( Asscher, AW; Roberts, DE; Webb, DB; Williams, JD, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (18.75) | 18.7374 |
| 1990's | 22 (45.83) | 18.2507 |
| 2000's | 8 (16.67) | 29.6817 |
| 2010's | 9 (18.75) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Avdeef, A | 1 |
| Tam, KY | 1 |
| Tang, RY | 1 |
| Cheong, BM | 1 |
| Zeidan, S | 1 |
| Esposito, L | 1 |
| Rostaing, L | 1 |
| Kamar, N | 1 |
| Benham, A | 1 |
| Davis, J | 1 |
| Puzio, C | 1 |
| Blakey, G | 1 |
| Slobodov, G | 1 |
| Kammoun, K | 1 |
| Jarraya, F | 1 |
| Makni, S | 1 |
| Ben Mahmoud, L | 1 |
| Kharrat, M | 1 |
| Ben Hmida, M | 1 |
| Zeghal, K | 1 |
| Boudawara, T | 1 |
| Hachicha, J | 1 |
| Vojinovic, RH | 1 |
| Milovanovic, DR | 1 |
| Dimic, ND | 1 |
| Radovanovic, M | 1 |
| Mitrovic, SLj | 1 |
| Radovanovic, DM | 1 |
| Shaki, F | 1 |
| Ashari, S | 1 |
| Ahangar, N | 1 |
| Acott, PD | 1 |
| Damuth, E | 1 |
| Heidelbaugh, J | 1 |
| Malani, PN | 1 |
| Cinti, SK | 1 |
| Artuković, M | 1 |
| Kustelega, J | 1 |
| Lugović-Mihić, L | 1 |
| Cekmen, MB | 1 |
| Bakirdoven, S | 1 |
| Sayan, M | 1 |
| Yilmaz, A | 1 |
| Dumarey, N | 1 |
| Schoutens, A | 1 |
| Ladhani, S | 1 |
| Gransden, W | 1 |
| Adams, BK | 1 |
| Youssef, I | 1 |
| Parkar, S | 1 |
| Song, JY | 1 |
| Jung, SJ | 1 |
| Park, CW | 1 |
| Sohn, JW | 1 |
| Kim, WJ | 1 |
| Kim, MJ | 1 |
| Cheong, HJ | 1 |
| Storsley, L | 1 |
| Geldenhuys, L | 1 |
| Thamboo, TP | 1 |
| Jeffery, KJ | 1 |
| Friend, PJ | 1 |
| Turner, GD | 1 |
| Roberts, IS | 1 |
| Goel, MC | 1 |
| Agarwal, MR | 1 |
| Misra, A | 1 |
| Haraoka, M | 2 |
| Matsumoto, T | 2 |
| Takahashi, K | 2 |
| Kubo, S | 2 |
| Tanaka, M | 2 |
| Kumazawa, J | 2 |
| Yu, H | 1 |
| Wang, HY | 1 |
| Sun, ZM | 1 |
| MacGowan, AP | 1 |
| White, LO | 1 |
| Brown, NM | 1 |
| Lovering, AM | 1 |
| McMullin, CM | 1 |
| Reeves, DS | 1 |
| Hoey, LL | 1 |
| Lake, KD | 1 |
| Chadwick, PR | 1 |
| Thomas, NB | 1 |
| Shah, A | 1 |
| Lettieri, J | 1 |
| Blum, R | 1 |
| Millikin, S | 1 |
| Sica, D | 1 |
| Heller, AH | 1 |
| Jick, S | 1 |
| Eckhardt, A | 1 |
| Borner, K | 2 |
| Keller, F | 1 |
| Zellner, D | 1 |
| Ohno, I | 1 |
| Shapiro, MA | 1 |
| Sesnie, JC | 1 |
| Desaty, TM | 1 |
| Griffin, TJ | 1 |
| Heifetz, CL | 1 |
| Houston, TK | 1 |
| Peacock, JE | 1 |
| Appel, RG | 1 |
| Cowan, RJ | 1 |
| Georgopoulos, A | 1 |
| Feistauer, SM | 1 |
| Graninger, W | 1 |
| Pfleger, S | 1 |
| Georgopoulos, M | 1 |
| Mokrzycki, MH | 1 |
| Yamase, H | 1 |
| Kohn, OF | 1 |
| Sorgel, F | 1 |
| Naber, KG | 1 |
| Kinzig, M | 1 |
| Mahr, G | 1 |
| Muth, P | 1 |
| Curran, KA | 1 |
| Peterson, JC | 1 |
| Croker, BP | 1 |
| Drane, WE | 1 |
| Tisher, CC | 1 |
| Oliver, RM | 1 |
| Waller, DG | 1 |
| Rubin, CM | 1 |
| Booth, LV | 1 |
| Krüger, HU | 1 |
| Schuler, U | 1 |
| Proksch, B | 1 |
| Göbel, M | 1 |
| Ehninger, G | 1 |
| Ruhnke, M | 1 |
| Trautmann, M | 1 |
| Hopfenmüller, W | 1 |
| Fraise, AP | 1 |
| Smith, SP | 1 |
| Plaisance, KI | 2 |
| Drusano, GL | 4 |
| Forrest, A | 3 |
| Weir, MR | 1 |
| Standiford, HC | 3 |
| Stuck, AE | 1 |
| Frey, FJ | 1 |
| Heizmann, P | 1 |
| Brandt, R | 1 |
| Weidekamm, E | 1 |
| Bevan, JS | 1 |
| Griffiths, GJ | 1 |
| Williams, JD | 2 |
| Gibby, OM | 1 |
| Bergan, T | 1 |
| Thorsteinsson, SB | 1 |
| Rohwedder, R | 1 |
| Scholl, H | 1 |
| Bayer, AS | 1 |
| Blomquist, IK | 1 |
| Kim, KS | 1 |
| Weir, M | 2 |
| Leslie, J | 1 |
| Gasser, TC | 1 |
| Ebert, SC | 1 |
| Graversen, PH | 1 |
| Madsen, PO | 1 |
| Plaisance, K | 1 |
| Emm, T | 1 |
| Webb, DB | 1 |
| Roberts, DE | 1 |
| Asscher, AW | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| BK Viremia and BK Virus Nephropathy Post Kidney Transplant Comparison of New Practices With Traditional Approach: A Combined Retrospective Chart Review and Prospective Observational Study[NCT02758288] | 0 participants (Actual) | Observational | 2015-09-30 | Withdrawn | |||
| Treatment of Febrile Infectious Disease Among Children in Hadera District Given the Final Diagnosis. Descriptive Study[NCT02313532] | 500 participants (Anticipated) | Observational | 2015-01-31 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for ciprofloxacin and Kidney Diseases
| Article | Year |
|---|---|
Does ciprofloxacin interact with cyclosporine?
Topics: Ciprofloxacin; Clinical Trials as Topic; Cyclosporine; Drug Interactions; Drug Therapy, Combination; | 1994 |
[Ciprofloxacin nephropathy, acyclovir nephropathy].
Topics: Acyclovir; Anti-Infective Agents; Antiviral Agents; Ciprofloxacin; Humans; Kidney Diseases | 1997 |
Gallium-67-citrate scanning of renal parenchymal malacoplakia.
Topics: Anti-Infective Agents; Ascorbic Acid; Ciprofloxacin; Citrates; Female; Gallium; Gallium Radioisotope | 1998 |
Comparative pharmacokinetics of ciprofloxacin and temafloxacin in humans: a review.
Topics: Aging; Anti-Infective Agents; Ciprofloxacin; Drug Interactions; Fluoroquinolones; Humans; Kidney Dis | 1991 |
2 trials available for ciprofloxacin and Kidney Diseases
| Article | Year |
|---|---|
Pharmacokinetics of intravenous ciprofloxacin in normal and renally impaired subjects.
Topics: Adult; Aged; Anti-Infective Agents; Ciprofloxacin; Creatinine; Demography; Disease Progression; Dose | 1996 |
Ciprofloxacin pharmacokinetics in patients with normal and impaired renal function.
Topics: Chromatography, High Pressure Liquid; Ciprofloxacin; Humans; Kidney Diseases; Kinetics; Klebsiella p | 1987 |
42 other studies available for ciprofloxacin and Kidney Diseases
| Article | Year |
|---|---|
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological | 2010 |
Multiple bilateral renal abscesses in a previously healthy young patient.
Topics: Abscess; Administration, Oral; Adolescent; Ceftazidime; Ciprofloxacin; Female; Humans; Infusions, In | 2017 |
The Achilles tendon of preventing BK virus nephropathy.
Topics: Achilles Tendon; Anti-Bacterial Agents; BK Virus; Ciprofloxacin; Humans; Kidney Diseases; Kidney Tra | 2013 |
Renal abscess yields elusive hypermucoviscous phenotype of, uropathogenic Escherichia coli: a case report.
Topics: Abscess; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Drainage; Escherichia coli Infections; F | 2013 |
Ciprofloxacin-induced crystal nephropathy.
Topics: Adolescent; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Ciprofloxacin; Crystalli | 2014 |
Hepatic abscess originating from renal suppurative collection.
Topics: Abdominal Pain; Abscess; Adult; Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Escherichia coli; Es | 2015 |
Melatonin can attenuate ciprofloxacin induced nephrotoxicity: Involvement of nitric oxide and TNF-α.
Topics: Animals; Ciprofloxacin; Creatinine; Glutathione; Kidney; Kidney Diseases; Kidney Function Tests; Lip | 2016 |
Current treatment of polyoma BK nephropathy in pediatric renal transplant patients.
Topics: BK Virus; Child; Cidofovir; Ciprofloxacin; Cytosine; Humans; Immunosuppressive Agents; Kidney Diseas | 2008 |
An elderly patient with fluoroquinolone-associated achilles tendinitis.
Topics: Aged; Anti-Infective Agents; Ciprofloxacin; Humans; Kidney Diseases; Male; Risk Factors; Tendinopath | 2008 |
DRESS syndrome with mild manifestations as a diagnostic and therapeutic problem: case report.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Diagnosis, Differential; Drug Eruptions; Eosinophilia; Female; | 2010 |
BK virus nephropathy developing after renal transplantation and its treatment with ciprofloxacin: a case report.
Topics: Antiviral Agents; BK Virus; Ciprofloxacin; Humans; Kidney Diseases; Kidney Transplantation; Male; Po | 2012 |
Renal abscess: filling in with Tc-99m ciprofloxacin of defects seen on Tc-99m DMSA SPECT.
Topics: Abscess; Adult; Ciprofloxacin; Female; Humans; Kidney; Kidney Diseases; Organotechnetium Compounds; | 2003 |
Increasing antibiotic resistance among urinary tract isolates.
Topics: Adolescent; Anti-Bacterial Agents; Cefuroxime; Child; Ciprofloxacin; Drug Resistance, Bacterial; Esc | 2003 |
Absent Tc-99m ciprofloxacin (infecton) uptake in a renal abscess.
Topics: Abscess; Adult; Ciprofloxacin; Humans; Kidney Diseases; Klebsiella Infections; Male; Organotechnetiu | 2006 |
Prognostic significance of infection acquisition sites in spontaneous bacterial peritonitis: nosocomial versus community acquired.
Topics: Aged; Anti-Bacterial Agents; Bacterial Infections; Cefotaxime; Ciprofloxacin; Community-Acquired Inf | 2006 |
Ciprofloxacin-induced ANCA-negative cutaneous and renal vasculitis--resolution with drug withdrawal.
Topics: Anti-Infective Agents; Biopsy; Ciprofloxacin; Diagnosis, Differential; Humans; Kidney; Kidney Diseas | 2007 |
Urine cytology screening for polyoma virus infection following renal transplantation: the Oxford experience.
Topics: Anti-Infective Agents; Ciprofloxacin; Humans; Immunosuppression Therapy; Kidney Diseases; Kidney Tra | 2007 |
Percutaneous drainage of renal hydatid cyst: early results and follow-up.
Topics: Adult; Albendazole; Ciprofloxacin; Drainage; Echinococcosis; Female; Follow-Up Studies; Humans; Kidn | 1995 |
Effect of prednisolone on ascending renal infection due to biofilm disease and lower urinary tract obstruction in rats.
Topics: Animals; Bacterial Infections; Biofilms; Cicatrix; Ciprofloxacin; Colony Count, Microbial; Drug Ther | 1995 |
[The pharmacokinetics of ciprofloxacin in patients with renal function of various degrees].
Topics: Adult; Ciprofloxacin; Dose-Response Relationship, Drug; Female; Half-Life; Humans; Kidney; Kidney Di | 1994 |
Serum ciprofloxacin concentrations in patients with severe sepsis being treated with ciprofloxacin 200 mg i.v. bd irrespective of renal function.
Topics: Adult; Aged; Bacterial Infections; Chromatography, High Pressure Liquid; Ciprofloxacin; Creatinine; | 1994 |
Suppression of renal scarring by prednisolone combined with ciprofloxacin in ascending pyelonephritis in rats.
Topics: Animals; Cicatrix; Ciprofloxacin; Drug Administration Schedule; Drug Therapy, Combination; Female; K | 1994 |
Conservative management of a patient with bilateral renal abscesses.
Topics: Abscess; Ceftazidime; Ciprofloxacin; Drug Therapy, Combination; Escherichia coli Infections; Floxaci | 1994 |
Ciprofloxacin safety in a pediatric population.
Topics: Adolescent; Anti-Infective Agents; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; | 1997 |
Dosage adjustment of antiinfective therapy in patients with renal impairment.
Topics: Aminoglycosides; Analysis of Variance; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infec | 1997 |
Comparative therapeutic efficacy of clinafloxacin in a Pseudomonas aeruginosa mouse renal abscess model.
Topics: Abscess; Animals; Anti-Infective Agents; Area Under Curve; Ceftazidime; Cilastatin; Cilastatin, Imip | 1998 |
Antibacterial activity of sparfloxacin against experimental renal infections in mice.
Topics: Abscess; Animals; Anti-Infective Agents; Ciprofloxacin; Escherichia coli Infections; Female; Fleroxa | 1992 |
Renal malacoplakia with papillary necrosis and renal failure.
Topics: Acute Kidney Injury; Alcoholism; Ciprofloxacin; Humans; Kidney Diseases; Kidney Papillary Necrosis; | 1992 |
Gallium scan in the diagnosis and treatment of renal malacoplakia.
Topics: Ciprofloxacin; Diagnosis, Differential; Escherichia coli Infections; Female; Gallium Radioisotopes; | 1990 |
Splenic and renal abscesses following Salmonella virchow septicaemia--conservative management with ciprofloxacin.
Topics: Abscess; Adult; Ciprofloxacin; Female; Humans; Kidney Diseases; Salmonella Infections; Sepsis; Splen | 1990 |
Investigation of potential interaction of ciprofloxacin with cyclosporine in bone marrow transplant recipients.
Topics: Adult; Bone Marrow Transplantation; Chromatography, High Pressure Liquid; Ciprofloxacin; Cyclosporin | 1990 |
Pharmacokinetics of ciprofloxacin in liver cirrhosis.
Topics: Administration, Oral; Adult; Ciprofloxacin; Female; Humans; Kidney Diseases; Liver Cirrhosis; Male; | 1990 |
Ciprofloxacin in combined renal and hepatic impairment.
Topics: Bacterial Infections; Ciprofloxacin; Female; Humans; Kidney Diseases; Liver Diseases; Middle Aged | 1990 |
Effect of renal function on the bioavailability of ciprofloxacin.
Topics: Administration, Oral; Adult; Biological Availability; Chronic Disease; Ciprofloxacin; Female; Glomer | 1990 |
Pharmacokinetics and metabolism of intravenous and oral fleroxacin in subjects with normal and impaired renal function and in patients on continuous ambulatory peritoneal dialysis.
Topics: Administration, Oral; Adult; Aged; Anti-Infective Agents; Ciprofloxacin; Female; Fleroxacin; Glomeru | 1989 |
Bilateral renal cortical abscesses in a young woman with type 1 diabetes.
Topics: Abscess; Adult; Cephradine; Ciprofloxacin; Cloxacillin; Diabetes Mellitus, Type 1; Drug Therapy, Com | 1989 |
Elimination of ciprofloxacin and three major metabolites and consequences of reduced renal function.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Chromatography, High Pressure Liquid; Ciprofl | 1989 |
Ciprofloxacin in experimental aortic valve endocarditis due to Pseudomonas aeruginosa.
Topics: Abscess; Animals; Anti-Infective Agents; Aortic Valve; Azlocillin; Ciprofloxacin; Drug Therapy, Comb | 1986 |
Relationships between renal function and disposition of oral ciprofloxacin.
Topics: Administration, Oral; Adult; Ciprofloxacin; Creatinine; Female; Humans; Kidney; Kidney Diseases; Mal | 1988 |
An overview of the pharmacology of intravenously administered ciprofloxacin.
Topics: Ciprofloxacin; Creatinine; Half-Life; Humans; Infusions, Intravenous; Kidney; Kidney Diseases; Kinet | 1987 |
Pharmacokinetics of intravenously administered ciprofloxacin in patients with various degrees of renal function.
Topics: Adult; Ciprofloxacin; Creatinine; Female; Half-Life; Humans; Injections, Intravenous; Kidney Disease | 1987 |
Pharmacokinetics of ciprofloxacin in healthy volunteers and patients with impaired kidney function.
Topics: Adult; Aged; Body Weight; Ciprofloxacin; Creatinine; Female; Humans; Kidney; Kidney Diseases; Kineti | 1986 |